Source: International Congress 2017 – Lung cancer: clinical research on exhaled breath, clinical trials in advanced NSCLC and real-life appraisals of immunotherapies



Rating:

Share or cite this content

Citations should be made in the following way:
R. de Vries (Amsterdam, Netherlands). Exhaled Breath Analysis for Prediction of Response to Anti-PD1 Therapy in Patients with NSCLC. 1473

Member's Comments

No comment yet.

Related content which might interest you: Can Exhaled Nitric Oxide Be a Biomarker for Hospitalized and Post-COVID-19 Patients? Source: Virtual Congress 2021 – Biological and functional markers of COVID-19 Year: 2021 Does Exhaled Nitric Oxide Correlate with Established Measures of Asthma Severity? Source: International Congress 2018 – Biomarkers for evaluating asthma Year: 2018 MCC-IMS Analyses of Volatile Markers from Exhaled Air for Detection of Bacterial Infection between nasal suction and exhalation through Mouth Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019 Exhaled Breath Biomarkers in Sarcoidosis: A Systematic Review Source: International Congress 2018 – Granulomatous disorders: heterogeneous diseases with variable management Year: 2018 Correlation between Blood Eosinophilia and Fractional Exhaled Nitric Oxide in the diagnosis of Asthma within Primary Care. Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020 MDCT Parametric Response Mapping Identifies Loss of Lung Terminal Bronchioles in COPD Source: International Congress 2017 – Imaging markers for COPD and asthma Year: 2017 Late Breaking Abstract - Metabolomics in Exhaled Breath Condensate (EBC) of asthmatic patients. Does severity and methodology make the difference? Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Late Breaking Abstract - TriOptimize VIII – Improvement of Lung Function with Extrafine Single Inhaler Triple Therapy – Analysis of Response Patterns by Prior Treatment from a Real-World Study. Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Performance of Super ARMS to Detect EGFR Mutation Status in Plasma Cell-free DNA in Advanced Non-Small Cell Lung Cancer Patients Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017 Effect of Peri-operative Bronchodilator Therapy on Postoperative Pulmonary Function among Lung Cancer Patients with COPD Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Investigation of the Relationship Between Breath Retention Time and Blood Parameters in Stroke Patients Source: Virtual Congress 2020 – Advances in lung function testing Year: 2020 Correlation of the Distance Saturation Product with spirometric and Diffusion Capacity for Carbon Monoxide data in patients with Interstitial Lung disease Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases Year: 2021 Differential expression of miRNAs in Exhaled Breath Condensate (EBC) and EBUS-TBNA of patients with Mediastinal Tuberculosis and Pulmonary Sarcoidosis Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020 Characterization of Patients with KRAS-Mutated Advanced Non-Small Cell Lung Cancer Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology Year: 2019 Late Breaking Abstract -  Bacterial Load and Inflammation in Sputum from patients with Alpha-1-Antitrypsin Deficiency as compared with COPD Patients Source: International Congress 2017 – Novel mechanisms and treatments for COPD Year: 2017 LATE-BREAKING ABSTRACT: Blood Eosinophil Count as a Biomarker of ICS Effectiveness in Reducing Exacerbation Rates in COPD Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Exhaled Volatile Organic Compounds are Able to Diagnose Systemic Sclerosis Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis Year: 2020 Comparison of Fractional Nitric Oxide in Exhaled Breath in bronchial asthma and COPD Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers Year: 2017 LATE-BREAKING ABSTRACT: Is Blood Eosinophil Count a Predictor of Response to Bronchodilators in COPD? Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Comprehensive Metabolic Profiling Reveals Metabolic Perturbances and Identifies Potential Biomarkers in Chronic Persistent Bronchial Asthma with Different Levels of Eosinophilia Percentage Source: International Congress 2019 – Evaluation of basic science in airway diseases Year: 2019